Entest Biomedical Inc
Entest Group, Inc. does not have significant operations. It intends to seek business opportunities to review and analyze for purposes of effecting a merger, acquisition, or other business combination with an operating company business. The company was formerly known as Entest Biomedical, Inc. and changed its name to Entest Group, Inc. in February 2018. Entest Group, Inc. was founded in 2008 and i… Read more
Entest Biomedical Inc (ETNI) - Total Liabilities
Latest total liabilities as of November 2019: $50.66K USD
Based on the latest financial reports, Entest Biomedical Inc (ETNI) has total liabilities worth $50.66K USD as of November 2019.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Entest Biomedical Inc - Total Liabilities Trend (2009–2019)
This chart illustrates how Entest Biomedical Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Entest Biomedical Inc Competitors by Total Liabilities
The table below lists competitors of Entest Biomedical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jr Global Reit
KO:348950
|
Korea | ₩1.59 Trillion |
|
Rocca SA
WAR:RCA
|
Poland | zł1.44 Million |
Liability Composition Analysis (2009–2019)
This chart breaks down Entest Biomedical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | N/A | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Entest Biomedical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Entest Biomedical Inc (2009–2019)
The table below shows the annual total liabilities of Entest Biomedical Inc from 2009 to 2019.
| Year | Total Liabilities | Change |
|---|---|---|
| 2019-08-31 | $32.67K | -87.19% |
| 2018-08-31 | $255.02K | -20.14% |
| 2017-08-31 | $319.35K | -68.15% |
| 2016-08-31 | $1.00 Million | +24.17% |
| 2015-08-31 | $807.54K | +17.06% |
| 2014-08-31 | $689.84K | -6.98% |
| 2013-08-31 | $741.57K | +26.63% |
| 2012-08-31 | $585.63K | +52.41% |
| 2011-08-31 | $384.25K | +25.57% |
| 2010-08-31 | $306.00K | +12893.76% |
| 2009-08-31 | $2.35K | -- |